Sten Madsbad

Sten Madsbad

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


  1. Published

    Additive effects of glucagon-like peptide 1 and pioglitazone in patients with type 2 diabetes.

    Olsen, Ane Mette Zander, Christiansen, A., Madsbad, Sten & Holst, Jens Juul, 2004, In: Diabetes Care. 27, 8, p. 1910-4 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Effect of weight reductions on estimated kidney function: Post-hoc analysis of two randomized trials

    von Scholten, B. J., Davies, M. J., Persson, F., Hansen, T. W., Madsbad, Sten, Endahl, L., Jepsen, C. H. & Rossing, Peter, 2017, In: Journal of Diabetes and its Complications. 31, 7, p. 1164-1168

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Effect of large weight reductions on measured and estimated kidney function

    von Scholten, B. J., Persson, F., Svane, M. S., Hansen, T. W., Madsbad, Sten & Rossing, Peter, 6 Feb 2017, In: B M C Nephrology. 18, 7 p., 52.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Treatment potential of the GLP-1 receptor agonists in type 2 diabetes mellitus: a review

    Østergaard, L., Frandsen, C. S. & Madsbad, Sten, 2016, In: Expert Review of Clinical Pharmacology. 9, 2, p. 241-65 25 p.

    Research output: Contribution to journalReviewResearchpeer-review

  5. Published

    Fixed-ratio combination therapy with GLP-1 receptor agonist liraglutide and insulin degludec in people with type 2 diabetes

    Østergaard, L., Frandsen, C. S., Dejgaard, T. F. & Madsbad, Sten, Jun 2017, In: Expert Review of Clinical Pharmacology. 10, 6, p. 621-632 12 p.

    Research output: Contribution to journalReviewResearchpeer-review

Previous 1...44 45 46 47 48 Next

ID: 10877